HTG2014-Section-Header-publications

2018

Gene expression difference (GED) revealed immune function gene down-regulation as tumor-associated inflammatory cell (TAIC) infiltration in microenvironment in non-small cell lung cancer (NSCLC)

Wistuba, I., et al, Gene expression difference (GED) revealed immune function gene down-regulation as tumor-associated inflammatory cell (TAIC) infiltration in microenvironment in non-small cell lung cancer (NSCLC). Poster#4054 Presented at American Association for Cancer Research (AACR) Annual Meeting; 2018 Apr 14-18; Chicago, IL

Download ppt 1.9MB
View External Link

Fibroblast growth factor receptor 3 (FGFR3), peroxisome proliferator-activated receptor gamma (PPARg), and outcomes with nivolumab (nivo) in metastatic urothelial cancer (UC).

Galsky, M. et al. Fibroblast growth factor receptor 3 (FGFR3), peroxisome proliferator-activated receptor gamma (PPARg), and outcomes with nivolumab (nivo) in metastatic urothelial cancer (UC). Poster session presented at: Genitourniary Cancers Symposium; 2018 Feb 9; San Francisco, CA. J Clin Oncol 36, 2018 (suppl 6S; abstr 511).

View External Link

2017

Analysis of Expression of Immunomodulation Factors in Alveolar Soft-Part Sarcoma: A Retrospective Study from the Spanish Group for Research on Sarcoma

Hindi, N., et. al.,  Analysis of Expression of Immunomodulation Factors in Alveolar Soft-Part Sarcoma: A Retrospective Study from the Spanish Group for Research on Sarcoma. Poster presented at European Society for Medical Oncology (ESMO). 2017 Sept 8 - 12; Madrid, Spain.

Download pdf 526KB

Advanced molecular characterization of severe autoimmune toxicities associated with checkpoint inhibitor therapies

Balko J., et al. Advanced molecular characterization of severe autoimmune toxicities associated with checkpoint inhibitor therapies. Poster session presented at: The American Association for Cancer Research, 2017 Apr; Washington, DC

Download pdf 1.1MB

A Cross Comparison of Technologies for the Detection of Immune System Related Gene Expression Signatures in Clinical FFPE Samples of Metastatic Prostate Cancer Patients

Howard K., et al. A Cross Comparison of Technologies for the Detection of Immune System Related Gene Expression Signatures in Clinical FFPE Samples of Metastatic Prostate Cancer Patients.  Poster session presented at: The American Association of Cancer Research 2017 Apr; Washington, DC.

Download pdf 2.2MB

2016

Page last updated September 16, 2021